Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Incidence and predictors of immune checkpoint inhibitor treatment–related cognitive impairment in a racial and ethnic diverse population

Supportive Care in Cancer(2025)10.1007/s00520-025-09560-0Source: DataRank Database

Incidence and predictors of immune checkpoint inhibitor treatment–related cognitive impairment in a racial and ethnic diverse population is a research paper published in Supportive Care in Cancer (2025). On theSindex it has a DataRank of 0.208. It has been cited 3 times.

N/A

0.208DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.12)OA: hybridTopics (85)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.208

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (8)

Parisa Agrawal,Ding Quan Ng ORCID,Dalia Kagramanov,Julia Trudeau ORCID,Shivashankar Othy ORCID

Live enrichment

PubMed:40451933 PMC:PMC12127230 OpenAlex:https://openalex.org/W4410932550

US National Institutes of Health

Grant: R01CA276212

NCATS NIH HHS

Grant: UM1 TR004927

NIAID NIH HHS

Grant: R01 AI168063

National Institutes of Health

Grant: 5R01CA276212-02

Neurotrophic strategy to mitigate chemotherapy-related brain injury

Hematology/Oncology Pharmacy Association

FWCI

2.12

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s00520-025-09560-0.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00520-025-09560-0.pdf

publisherhttps://link.springer.com/article/10.1007/s00520-025-09560-0/fulltext.html

journalhttps://doi.org/10.1007/s00520-025-09560-0

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40451933

Fields of Study

Cancer-related cognitive impairment studiesBrain Metastases and TreatmentIntensive Care Unit Cognitive Disorders0302 clinical medicine03 medical and health sciences

MeSH Terms

Patient Reported Outcome MeasuresImmune Checkpoint InhibitorsAdultAgedAged, 80 and overEthnicityFemaleHumansLongitudinal StudiesMaleMiddle AgedNeoplasmsProspective StudiesRisk FactorsIncidenceSelf ReportCognitive Dysfunction

Keywords

MedicineAnxietyIncidence (geometry)PopulationDepression (economics)CognitionInternal medicineProspective cohort studyCohortOncologyPsychiatryImmunotherapyPatient-reported OutcomesImmune Checkpoint InhibitorsCancer-related Cognitive ImpairmentMale11 Medical and Health Sciences (for)Ethnicity (mesh)Clinical Research (rcdc)Brain Disorders (rcdc)Cognitive Dysfunction (mesh)Risk FactorsNeoplasms80 and over (mesh)EthnicityProspective StudiesLongitudinal Studies32 Biomedical and Clinical Sciences (for-2020)Male (mesh)Neurosciences (rcdc)Cancer (rcdc)Aged, 80 and overHumans (mesh)Neoplasms (mesh)3 Good Health and Well Being (sdg)Immune Checkpoint Inhibitors (mesh)52 Psychology (for-2020)IncidenceMiddle AgedFemaleBehavioral and Social Science (rcdc)Mental Health (rcdc)AdultIncidence (mesh)Risk Factors (mesh)42 Health sciences (for-2020)Middle Aged (mesh)Patient Reported Outcome Measures (mesh)HumansCognitive Dysfunction17 Psychology and Cognitive Sciences (for)Patient Reported Outcome MeasuresProspective Studies (mesh)AgedAged (mesh)ResearchLongitudinal Studies (mesh)3211 Oncology and Carcinogenesis (for-2020)Oncology & Carcinogenesis (science-metrix)Female (mesh)Adult (mesh)Self ReportSelf Report (mesh)

Sustainable Development Goals

SDG 0: Good health and well-being